Table 4

Predictors of percentage decline in eGFR at 5 years by linear regression

Individual predictors
95% CI
BβP-valueLower boundUpper bound
eGFR0.60.210.29−0.61.8
OPG0.0010.0610.72−0.0060.008
Ca/P product−3.5−0.070.67−2013.1
Calcidiol0.10.170.47−0.20.5
PTHa41.00.440.02776.6
%ucOC−0.1−0.100.57−0.60.4
UACRa140.40.0083.823.4
CACa9.90.40.0241.418.4
Constant−70.8
Individual predictors
95% CI
BβP-valueLower boundUpper bound
eGFR0.60.210.29−0.61.8
OPG0.0010.0610.72−0.0060.008
Ca/P product−3.5−0.070.67−2013.1
Calcidiol0.10.170.47−0.20.5
PTHa41.00.440.02776.6
%ucOC−0.1−0.100.57−0.60.4
UACRa140.40.0083.823.4
CACa9.90.40.0241.418.4
Constant−70.8
a

Prior to analysis, PTH, UACR and CAC were logarithmically transformed to ensure normality, with 1.0 added to CAC score prior to transformation.

Table 4

Predictors of percentage decline in eGFR at 5 years by linear regression

Individual predictors
95% CI
BβP-valueLower boundUpper bound
eGFR0.60.210.29−0.61.8
OPG0.0010.0610.72−0.0060.008
Ca/P product−3.5−0.070.67−2013.1
Calcidiol0.10.170.47−0.20.5
PTHa41.00.440.02776.6
%ucOC−0.1−0.100.57−0.60.4
UACRa140.40.0083.823.4
CACa9.90.40.0241.418.4
Constant−70.8
Individual predictors
95% CI
BβP-valueLower boundUpper bound
eGFR0.60.210.29−0.61.8
OPG0.0010.0610.72−0.0060.008
Ca/P product−3.5−0.070.67−2013.1
Calcidiol0.10.170.47−0.20.5
PTHa41.00.440.02776.6
%ucOC−0.1−0.100.57−0.60.4
UACRa140.40.0083.823.4
CACa9.90.40.0241.418.4
Constant−70.8
a

Prior to analysis, PTH, UACR and CAC were logarithmically transformed to ensure normality, with 1.0 added to CAC score prior to transformation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close